MDSCs are the primary producers of IL10 which, in turn, can limit the activity of helper T cells and cytotoxic T lymphocyte (CTL) against tumour cells by different mechanisms including decreasing the expression of major histocompatibility complex (MHC) class I on tumour cells [140]. Here, IL10 is linked to neoplasm.